Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
Recruiting
Observational Study
SSc-Systemic Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 35 (estimated)
- Sponsor
- University of Patras · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with ssc-ild receiving double immunosuppression with or without anti fibrotic tratment
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:ild-ssc with double immunosuppression
\-
Exclusion Criteria:
* ssc without ild
Contacts